A new variant of maple syrup urine disease (branched chain ketoaciduria): Clinical and biochemical evaluation
- 31 July 1970
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 49 (1) , 118-124
- https://doi.org/10.1016/s0002-9343(70)80121-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Enzyme defect in skin fibroblasts in intermittent branched-chain detonuria and in maple syrup urine diseaseBiochemical Medicine, 1969
- Alteration in the magnitude of induction of tyrosine transaminase by glucocorticoids. The effects of phenobarbital, o,p′DDD and β-diethylaminoethyl diphenylpropylacetate (SKF 525A)Archives of Biochemistry and Biophysics, 1968
- Biochemical studies on branched-chain oxoacid oxidasesBiochimica et Biophysica Acta (BBA) - Enzymology, 1967
- Detection of the heterozygote in maple syrup urine diseaseThe Journal of Pediatrics, 1965
- Late Manifesting Variant of Branched-Chain Ketoaciduria (Maple Syrup Urine Disease)Acta Paediatrica, 1964
- Ein weiterer Heterozygoten-Test für die Ahornsirupkrankheit (maple syrup urine disease)Klinische Wochenschrift, 1963
- The metabolism of leucine in tissue culture of skin fibroblasts of maple-syrup-urine diseaseBiochimica et Biophysica Acta, 1963
- Metabolism of the white blood cells in maple-syrup-urine diseaseBiochimica et Biophysica Acta, 1960
- "Maple Syrup Urine Disease"BMJ, 1959
- "Maple Syrup Urine Disease"BMJ, 1959